CT Pulmonary Angiography in a Patient with Renal Insufficiency and Suspected PE
A 71-year-old man with a creatinine of 2.1 mg/dL (eGFR approximately 28 mL/min/1.73 m²) presents with acute dyspnea and pleuritic chest pain. He is hemodynamically stable. The emergency physician orders a CT pulmonary angiogram. The technologist asks whether to proceed with the standard contrast protocol. The radiologist considers the tradeoffs: CTPA requires dense pulmonary arterial opacification, which typically demands a higher contrast volume and flow rate than many other studies. The patient's renal function places him at elevated risk for contrast-associated acute kidney injury, though the risk is modest and largely reversible. Alternative strategies include V/Q scan, lower-volume contrast technique, or pre-hydration.
1. What is the appropriate contrast strategy and why?
Read the worked answer
The appropriate approach is to proceed with CTPA using a reduced-volume, high-concentration contrast protocol (e.g., 40–50 mL of a high-iodine-concentration agent) with a saline chaser, rather than a standard 80–100 mL protocol. Rationale: (1) CTPA is the test of choice for suspected PE and is more sensitive than V/Q for small emboli; (2) contrast-associated AKI risk is dose-related and modest at eGFR ~28, so minimizing volume while preserving diagnostic opacification is the correct balance; (3) the patient is stable, so there is time to optimize technique but not to defer definitive imaging. Pre-hydration can be considered but is not mandatory at this eGFR and should not delay diagnosis. The reasoning requires weighing diagnostic yield against modifiable risk rather than applying a blanket 'avoid contrast' rule.
2. If the technologist's reduced-volume study yields suboptimal pulmonary arterial opacification, what should the radiologist do?
Read the worked answer
The radiologist should evaluate whether the study is diagnostic. If the main pulmonary arteries are adequately opacified to exclude central PE but segmental/subsegmental arteries are suboptimal, the study may still be sufficient for a clinical decision in a stable patient. If it is nondiagnostic, options are: repeat with a slightly higher volume (accepting incremental risk), switch to V/Q scan (which requires no iodinated contrast and is reasonable in a stable patient with a normal chest radiograph), or perform lower-extremity venous ultrasound to support management. The reasoning is that a nondiagnostic test is not a neutral event-it consumes contrast and time without answering the question-so the radiologist must decide whether to escalate or pivot to a non-contrast modality based on the clinical question and patient stability.
3. How should the recommendation be communicated, and what documentation is required?
Read the worked answer
The radiologist should document the renal function, the rationale for the modified contrast protocol, and the result quality. If a V/Q scan is recommended, the report should state why (renal function, nondiagnostic CTPA). Direct communication with the emergency physician is warranted when the study is nondiagnostic or when the recommendation changes management, because the patient is in an acute care setting. This reflects the noninterpretive competencies of closed-loop communication and appropriate documentation of risk-benefit decisions.